Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · see citing works

Polymer-based nanocapsules for drug delivery

Mora‐Huertas, C. E., Fessi, H., & Elaı̈ssari, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,744 · see citing works

Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs

Gürsoy, R. N., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358 · see citing works

Nanocrystal technology, drug delivery and clinical applications

Müller, R. H., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 954 · see citing works

Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies

Pouton, C. W., & Porter, C. J. H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 887 · see citing works

Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆

Almeida, A. J., & Souto, E. B. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 817 · see citing works

Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications

Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 796 · see citing works

Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives

Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740 · see citing works

Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products

Eerdenbrugh, B. V., den Mooter, G. V., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 719 · see citing works

Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo

Mittal, G., Sahana, D. K., Bhardwaj, V., & Kumar, M. N. V. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 549 · see citing works

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 536 · see citing works

Self-Nanoemulsifying Drug Delivery Systems: Formulation Insights, Applications and Advances

Date, A. A., Desai, N., Dixit, R. P., et al. (2010) · Nanomedicine · doi:10.2217/nnm.10.126 · Cited by 499 · see citing works

Production methods for nanodrug particles using the bottom-up approach

Chan, H., & Kwok, P. C. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.011 · Cited by 451 · see citing works

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394 · see citing works

Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms

Tang, B., Cheng, G., Gu, J.-C., & Xu, C. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.04.006 · Cited by 393 · see citing works

Lipid-Based Delivery Systems for Improving the Bioavailability and Lymphatic Transport of a Poorly Water-Soluble LTB4 Inhibitor

Hauss, D. J., Fogal, S. E., FICORILLI, J. V., Price, C. A., Roy, T., Jayaraj, A. A., & Keirns, J. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970300n · Cited by 316 · see citing works

Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats

Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294 · see citing works

Surface Acetylation of Polyamidoamine (PAMAM) Dendrimers Decreases Cytotoxicity while Maintaining Membrane Permeability

Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., et al. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603889 · Cited by 287 · see citing works

Oral solid lipid nanoparticle-based antitubercular chemotherapy

Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271 · see citing works

PLGA Nanoparticles for Oral Delivery of Hydrophobic Drugs: Influence of Organic Solvent on Nanoparticle Formation and Release Behavior In Vitro and In Vivo Using Estradiol as a Model Drug

Sahana, D. K., Mittal, G., Bhardwaj, V., & Kumar, M. N. V. R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21158 · Cited by 260 · see citing works

Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration

Cole, E. T., Cadé, D., & Benameur, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.009 · Cited by 241 · see citing works

Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage

Abdelwahed, W., Degobert, G., & Fessi, H. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.015 · Cited by 222 · see citing works

Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs

Gao, P., & Morozowich, W. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.97 · Cited by 221 · see citing works

PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®

Italia, J. L., Bhatt, D. K., Bhardwaj, V., Tikoo, K., & Kumar, M. N. V. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.004 · Cited by 203 · see citing works

Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation

Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199 · see citing works

Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease

Kriegel, C., & Amiji, M. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.002 · Cited by 176 · see citing works

Preparation and Evaluation of SEDDS and SMEDDS Containing Carvedilol

Wei, L., Sun, P., Nie, S., et al. (2005) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500216428 · Cited by 173 · see citing works

Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs

Tan, A., Simović, S., Davey, A. K., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.014 · Cited by 163 · see citing works

Self-nanoemulsifying granules of ezetimibe: Design, optimization and evaluation

Dixit, R., & Nagarsenker, M. S. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.013 · Cited by 153 · see citing works

Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs

Rao, S. V. R., Yajurvedi, K., & Shao, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.015 · Cited by 122 · see citing works

Facilitated nanoscale delivery of insulin across intestinal membrane models

Woitiski, C. B., Sarmento, B. F. C. C., Carvalho, R. A., Neufeld, R. J., & Veiga, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.003 · Cited by 121 · see citing works

Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin

Morçöl, T., Nagappan, P., Nerenbaum, L., Mitchell, A., & Bell, S. J. D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.07.015 · Cited by 112 · see citing works

Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers

Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 99 · see citing works

Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion

Nicolaos, G. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00365-x · Cited by 84 · see citing works

Controlled Release of Oral Tetrahydrocurcumin from a Novel Self-Emulsifying Floating Drug Delivery System (SEFDDS)

Setthacheewakul, S., Kedjinda, W., Maneenuan, D., & Wiwattanapatapee, R. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9568-8 · Cited by 67 · see citing works

Acute and Subacute Toxicity Studies of Chitosan Reduced Gold Nanoparticles: A Novel Carrier for Therapeutic Agents

Pokharkar, V., Dhar, S., Bhumkar, D. R., et al. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1027 · Cited by 58 · see citing works

Gold Nanoparticles as a Potential Carrier for Transmucosal Vaccine Delivery

Pokharkar, V., Bhumkar, D. R., Suresh, K., et al. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1200 · Cited by 54 · see citing works

Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: Preparation and evaluation

Guo, F., Zhong, H., He, J. N., et al. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0709-8 · Cited by 49 · see citing works

Spray-drying Nanocapsules in Presence of Colloidal Silica as Drying Auxiliary Agent: Formulation and Process Variables Optimization Using Experimental Designs

Tewa-Tagne, P., Degobert, G., Briançon, S., et al. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9182-3 · Cited by 47 · see citing works

Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives

Grama, C. N., Ankola, D. D., & Kumar, M. N. V. R. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.11.005 · Cited by 44 · see citing works

Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure® in Treating Hyperlipidemia

Meena, A. K., Ratnam, D. V., Chandraiah, G., Ankola, D. D., Rao, P. R., & Kumar, M. N. V. R. (2008) · Lipids · doi:10.1007/s11745-007-3142-5 · Cited by 40 · see citing works

Eudragit EPO Nanoparticles: Application in Improving Therapeutic Efficacy and Reducing Ulcerogenicity of Meloxicam on Oral Administration

Khachane, P., Date, A. A., & Nagarsenker, M. S. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1322 · Cited by 40 · see citing works

Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles

Chakraborty, S., Shukla, D., Vuddanda, P. R., et al. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.07.058 · Cited by 39 · see citing works

High Plasma Levels and Effective Lymphatic Uptake of Docetaxel in an Orally Available Nanotransporter Formulation

Nassar, T., Attili-Qadri, S., Harush-Frenkel, O., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3118 · Cited by 35 · see citing works

Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium

Gavini, E., Spada, G., Rassu, G., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01220.x · Cited by 30 · see citing works

Development of a Novel Self-Microemulsifying Drug Delivery System for Reducing HIV Protease Inhibitor-Induced Intestinal Epithelial Barrier Dysfunction

Lei, B., Zha, W., Wang, Y., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100003r · Cited by 16 · see citing works

Comparison of the Solubility and Dissolution Rate Between Gliclazide Solid Complex and Its Nanospheres

Lo, Y.-K., Chen, C.-J., Tsai, T., & Cham, T. (2007) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600920622 · Cited by 7 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

The emergence of nanocarriers in the management of diseases and disorders

Khulbe, P., Singh, D., Aman, A., et al. (2023) · Community Acquired Infection · doi:10.54844/cai.2022.0139 · Cited by 5 · see citing works

Delivery of Doxorubicin Using Double-Layered Core–Shell Nanocarrier Based on Magnetic Fe 3 O 4 Core and Salep Shells

Hosseini, S. H., Alipour, S., & Zohreh, N. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02390 · Cited by 20 · see citing works

Strategies for ligand-installed nanocarriers

Miyazaki, T., Nakagawa, Y., & Cabral, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821506-7.00024-7 · Cited by 3 · see citing works

General justification in terms of effectiveness and toxicities for the use of nanocarriers

Handali, S., & Rezaei, M. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05826-y · Cited by 3 · see citing works

Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel

Baek, J.-S., Shin, S., & Cho, C. (2012) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-012-0038-z · Cited by 20 · see citing works